Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging.

about

Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging.

Item

http://www.wikidata.org/entity/Q47137741

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging.

@en

Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging.

@nl

type

Item

label

Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging.

@en

Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging.

@nl

prefLabel

Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging.

@en

Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging.

@nl

P1476

Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging.

@en

P2093

Eun-Ah Park

http://www.w3.org/2001/XMLSchema#string

J Paul Finn

http://www.w3.org/2001/XMLSchema#string

Peng Hu

http://www.w3.org/2001/XMLSchema#string

Takegawa Yoshida

http://www.w3.org/2001/XMLSchema#string

P2860

The role of hepcidin in iron metabolism.

Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron

A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy

Free-breathing 3D whole-heart black-blood imaging with motion sensitized driven equilibrium.

Cardiac MR imaging: state of the technology.

Safety Report of Ferumoxytol for Magnetic Resonance Imaging in Children and Young Adults

Lower extremity deep venous thrombosis: evaluation with ferumoxytol-enhanced MR imaging and dual-contrast mechanism--preliminary experience.

Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients.

Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?

Effective motion-sensitizing magnetization preparation for black blood magnetic resonance imaging of the heart.

P2888

s12968-017-0422-y

P304

106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12968-017-0422-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kim-Lien Nguyen

P577

2017-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100103619

http://www.w3.org/2001/XMLSchema#string

P698

29284494

http://www.w3.org/2001/XMLSchema#string

P932

5745904

http://www.w3.org/2001/XMLSchema#string